AH
MRNA icon

Andreas Halvorsen’s Moderna MRNA Stock Holding History

Andreas Halvorsen’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-994,886
Closed -$29.8M – 82
2020
Q1 		$29.8M Sell
994,886
-2,326,869
-70% -$53.5M 0.16% 56
2019
Q4 		$65M Sell
3,321,755
-1,356,026
-29% -$24.1M 0.3% 51
2019
Q3 		$74.5M Sell
4,677,781
-3,519,677
-43% -$52M 0.39% 42
2019
Q2 		$120M Sell
8,197,458
-8,470,408
-51% -$182M 0.54% 38
2019
Q1 		$339M Sell
16,667,866
-413,298
-2% -$7.67M 1.95% 20
2018
Q4 		$261M Buy
+17,081,164
New +$281M 1.48% 20

Other funds holding MRNA

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Andreas Halvorsen's MRNA Position: Q2 2020 in Review

Andreas Halvorsen sold out of Moderna (MRNA) in Q2 2020, closing a stake of 994,886 shares — an estimated $29.8M sold.

Andreas Halvorsen first reported a position in MRNA in Q4 2018 and held it in 6 quarters. The position peaked at $339M in Q1 2019. 490 funds tracked by Wall St. Rank hold MRNA as of Q2 2020.

  • Andreas Halvorsen reported no remaining Moderna position as of Q2 2020 after selling out during the quarter.
  • Andreas Halvorsen sold 994,886 Moderna shares in Q2 2020, an estimated $29.8M.
  • Andreas Halvorsen first reported a position in Moderna in Q4 2018 and held it in 6 quarters.
  • Andreas Halvorsen's Moderna position peaked at $339M in Q1 2019.
  • 490 funds tracked by Wall St. Rank held Moderna as of Q2 2020.

Based on Viking Global Investors's 13F filing for Q2 2020, filed 7 Aug 2020.